AHEAD of winter specific groups are being offered a Covid vaccine booster shot to top up their protection against coronavirus. Side effects of the vaccines have been catalogued throughout the campaign – how will the booster shots compare?
SAN ANTONIO – For decades, the prices of procedures at most hospitals have been nearly impossible to find.
Now, hospitals in the U.S., including San Antonio, are posting the prices of their medical procedures online as a new federal rule and state law takes effect.
The mandates require hospitals to make public the costs of procedures, including those charged to insurance companies through negotiated rates and cash prices charged to uninsured patients.
A federal rule aimed at increasing transparency and helping people save money by comparing rates went into effect in January and was created by the Trump administration in 2019, according to a Kaiser Health News article.
The Texas Legislature followed that federal rule by passing a similar state law this year in Senate Bill 1137. Recently signed by Gov. Greg Abbott, the Texas Pricing Transparency Act takes effect Sept. 1.
Still, the price estimator tools are not front and center on most hospitals’ websites. KSAT has posted links to the local hospitals below.
If you are looking for prices from other hospitals, you can try using a search engine like Google and terms including the name of the hospital and “hospital prices” or “price estimator tools.”
According to an NPR article by Julie Appleby, it’s still an unanswered question whether the price transparency mandates will lead to lower prices for patients and it can be confusing for some.
Author: Raven Jordan
Read more here >>> Texas News
Since GB News’ opening night, things haven’t gotten much better in terms of the technical side of things.
The news channel has faced a variety of technical blunders, advertisers pulling their campaigns, and an embarrassing on-air prank.
Further revelation shows GB News has sparked a flood of Ofcom complaints, with hundreds contacting the broadcasting watchdog over Dan Wootton’s show.
The former The Sun showbiz journalist began his show on Sunday evening with a monologue over the then-rumoured delay to England’s delaying of lockdown easing.
Ofcom is said to have received 373 complaints after Mr Wootton said: “It’s increasingly clear now that there is a move among some pubic health officials and politicians to create an ultra-cautious biosecurity state, copying the likes of China.”
The UK has approved the use of a fourth coronavirus vaccine today, the Johnson & Johnson jab. This vaccine differs from those already available as it is a single-dose vaccine, rather than requiring two separate shots. The vaccine was developed by Johnson & Johnson’s pharmaceutical arm, Janssen.
Announcing the Medicines and Healthcare products Regulatory Agency (MHRA) had approved the safety of the jab, Health Secretary Matt Hancock said: “This is a further boost to the UK’s hugely successful vaccination programme, which has already saved over 13,000 lives, and means that we now have four safe and effective vaccines approved to help protect people from this awful virus.”As Janssen is a single-dose vaccine, it will play an important role in the months to come as we redouble our efforts to encourage everyone to get their jabs and potentially begin a booster programme later this year.”
The UK has placed an order for 20 million doses of the vaccine, which may be used for people in harder to reach areas as with just one dose needed, requesting a second appointment would not be needed.
So what do we know about the Johnson & Johnson vaccine?
The Johnson & Johnson vaccine is an adenovirus vaccine.
Vaccines of this type are based on weakened versions of adenoviruses.
Adenoviruses are a group of viruses that typically infect membranes of the eyes, respiratory tract, urinary tract, intestines and nervous system, and include the common cold.
Like the Oxford/AstraZeneca jab, the J&J vaccine uses viral vector technology where a modified version of a different virus is used to deliver instructions to the body’s cells.
This then triggers the immune system to begin producing antibodies.
How effective is the Johnson & Johnson vaccine?
The J&J vaccine has been shown to be 67 percent effective overall at preventing moderate to severe Covid-19.
Studies have suggested the jab also offers complete protection from admission to hospital and death.
Johnson & Johnson has said the vaccine works across multiple variants of coronavirus.
In a clinical trial involving 43,783 people, published earlier this year, the level of protection against moderate to severe Covid-19 infection was found to be 72 percent in the United States arm of the trial.
It was 66 percent in the Latin American arm of the trial, and 57 percent in the South African arm, where a mutant variant of the virus has been dominating.
The overall efficacy from these trials combined was 67 percent.Comparatively, the Moderna vaccine – which requires two doses – was found to be 50.8 percent effective up to 14 days after the first dose.
After two weeks, effectiveness was around 92.1 percent.
Following the second dose of Moderna your body will reach full immunity in around two weeks.
After this, the vaccine is approximately 94.1 percent effective.
Elsewhere, a study by the Korea Disease Control and Prevention Agency (KDCA) showed the Pfizer vaccine was 89.7 percent effective in preventing infection at least two weeks after a first dose was given.The same data found the AstraZeneca shot was 86.0 percent effective.
The study’s results are based on more than 3.5 million people in South Korea aged 60 and older for two months from February 26.
It included 521,133 people who received a first dose of either Pfizer or AstraZeneca shot.
What about risk of blood clots after the Johnson & Johnson vaccine?
The MHRA is believed to have stalled early approval of the vaccine after concerns were raised in the US about a link to extremely rare blood clots.
The clots are similar to those seen in a very small proportion of people having the Oxford/AstraZeneca jab.
In April, the European Medicines Agency said a warning about unusual blood clots with low blood platelet count should be added to the product information for the vaccine.
This followed eight cases of blood clots in more than seven million people vaccinated in the US.